CHA ACO, LLC
ACO Name and Location
CHA ACO, LLC
3245 Health Dr, Suite 100
Granger, IN 46530
ACO Primary Contact
Barbara Garrett
574-647-1845
bgarrett@beaconhealthsystem.org
Organizational Information
ACO Participants:
|
ACO Participants |
ACO Participant in Joint Venture |
|
Beacon Health Ventures, Inc |
No |
|
Beacon Health, LLC |
No |
|
Beacon Medical Group, Inc. |
No |
|
Community Hospital of Bremen, Inc |
No |
|
Elkhart General Hospital, Inc |
No |
|
Memorial Hospital of South Bend |
No |
|
South Bend Emergency Physicians, Inc |
No |
|
South Bend Medical Foundation, Inc. |
No |
ACO Governing Body:
|
Member |
Member |
Member Title/Position |
Member’s Voting Power (Expressed as a percentage) |
Membership Type |
ACO Participant Legal Business Name, if applicable |
|
Carl |
Risk |
Chairman |
14.3%
|
ACO Participant Representative |
Elkhart General Hospital, Inc. |
|
Cheryl |
Wibbens |
Voting |
14.2%
|
Medicare Beneficiary Representative
|
N/A |
|
Keyna |
Martinez |
Medical Director |
0% |
ACO Participant Representative |
Beacon Medical Group, Inc. |
|
Dale |
Patterson, MD |
Voting Member |
14.3% |
ACO Participant Representative |
Beacon Medical Group, Inc. |
|
Mark |
Schmeltz, DO |
Secretary |
14.3% |
ACO Participant Representative |
Beacon Medical Group, Inc. |
|
Sam |
El-Dalati, MD |
Voting |
14.3% |
ACO Participant Representative |
Beacon Medical Group, Inc. |
|
Sandra |
Brown, MD |
Treasurer |
14.3% |
ACO Participant Representative |
Beacon Medical Group, Inc. |
|
Scott |
Eshowsky |
Vice Chairman |
14.3% |
ACO Participant Representative |
Beacon Medical Group, Inc. |
Member's voting power may have been rounded to reflect a total voting power of 100 percent.
Key ACO Clinical and Administrative Leadership:
ACO Executive: Barbara Garrett
Medical Director: Keyna Martinez
Compliance Officer: Christine Atkins
Quality Assurance/Improvement Officer: Barbara Garrett
Associated Committees and Committee Leadership:
|
Committee Name |
Committee Leader Name and Position |
|
Finance and Contracting Committee |
Harley McCoige, Chairman |
|
Utilization/Quality Committee |
Keyna Martinez, MD, Medical Director |
Types of ACO Participants, or Combinations of Participants, That Formed the ACO:
- ACO professionals in a group practice arrangement
- Partnerships or joint venture arrangements between hospitals and ACO professionals
Shared Savings and Losses
Amount of Shared Savings/Losses:
Fourth Agreement Period
- Performance Year 2026, N/A
- Performance Year 2025, N/A
Third Agreement Period
- Performance Year 2024, $3,718,440.27
- Performance Year 2023, $3,508,762.61
- Performance Year 2022, $3,198,018.00
- Performance Year 2021, $2,628,311.92
- Performance Year 2020, $4,679,204.50
Second Agreement Period
- Performance Year 2019, $3,397,662.59
- Performance Year 2018, $0
- Performance Year 2017, N/A
First Agreement Period
- Performance Year 2016, N/A
- Performance Year 2015, N/A
- Performance Year 2014, N/A
Shared Savings Distribution:
Fourth Agreement Period
- Performance Year 2026
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2025
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
Third Agreement Period
- Performance Year 2024
- Proportion invested in infrastructure:
- Proportion invested in redesigned care processes/resources:
- Proportion of distribution to ACO participants:
- Performance Year 2023
- Proportion invested in infrastructure:
- Proportion invested in redesigned care processes/resources:
- Proportion of distribution to ACO participants:
- Performance Year 2022
- Proportion invested in infrastructure:
- Proportion invested in redesigned care processes/resources:
- Proportion of distribution to ACO participants:
- Performance Year 2021
- Proportion invested in infrastructure:
- Proportion invested in redesigned care processes/resources:
- Proportion of distribution to ACO participants:
- Performance Year 2020
- Proportion invested in infrastructure:
- Proportion invested in redesigned care processes/resources:
- Proportion of distribution to ACO participants:
Second Agreement Period
- Performance Year 2019
- Proportion invested in infrastructure:
- Proportion invested in redesigned care processes/resources:
- Proportion of distribution to ACO participants:
- Performance Year 2018
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2017
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
First Agreement Period
- Performance Year 2016
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2015
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/res
Quality Performance Results
2024 Quality Performance Results are based on CMS Web Interface:
ACO#
Measure Name
Rate
ACO Mean
CAHPS-1
CAHPS: Getting Timely Care, Appointments, and Information
86.15
83.70
CAHPS-2
CAHPS: How Well Your Providers Communicate
93.71
93.96
CAHPS-3
CAHPS: Patients’ Rating of Provider
93.08
92.43
CAHPS-4
CAHPS: Access to Specialists
78.87
75.76
CAHPS-5
CAHPS: Health Promotion and Education
59.51
65.48
CAHPS-6
CAHPS: Shared Decision Making
67.53
62.31
CAHPS-7
CAHPS: Health Status/Functional Status
76.60
74.14
CAHPS-8
CAHPS: Care Coordination
85.58
85.89
CAHPS-9
CAHPS: Courteous and Helpful Office Staff
94.76
92.89
CAHPS-11
CAHPS: Stewardship of Patient Resources
29.97
26.98
321
CAHPS for MIPS
7.59
6.67
479
Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups
0.1537
0.1517
484
Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC)
-
37.00
318
Falls: Screening for Future Fall Risk
83.25
88.89
110
Preventative Care and Screening: Influenza Immunization
51.67
68.60
226
Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention
75.00
79.98
113
Colorectal Cancer Screening
74.03
77.81
112
Breast Cancer Screening
81.02
80.93
438
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
84.70
86.50
370
Depression Remission at Twelve Months
13.27
17.35
001
Diabetes: Hemoglobin A1c (HbA1c) Poor Control
9.91
9.44
134
Preventative Care and Screening: Screening for Depression and Follow-up Plan
78.14
81.46
236
Controlling High Pressure
70.40
79.49
For previous years’ financial and quality performance results, please visit data.cms.gov
*For Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) [Quality ID #001], Hospital-Wide, 30-Day,All-Cause Unplanned Readmission (HWR) Rate for MIPS Eligible Clinician Groups [Measure #479], andClinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with MultipleChronic Conditions (MCC) [Measure #484], a lower performance rate indicates better measureperformance.*For Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with MultipleChronic Conditions (MCC) [Measure #484], patients are excluded if they were attributed to QualifyingAlternative Payment Model (APM) Participants (QPs). Most providers participating in Track E andENHANCED track ACOs are QPs, and so performance rates for Track E and ENHANCED track ACOsmay not be representative of the care provided by these ACOs' providers overall. Additionally, many ofthese ACOs do not have a performance rate calculated due to not meeting the minimum of 18beneficiaries attributed to non-QP providers.Payment Rule Waivers
- Skilled Nursing Facility (SNF) 3-day Rule Waiver:
- Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR § 425.612.
- Skilled Nursing Facility (SNF) 3-day Rule Waiver: